Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

NASDAQ:MACK

Merrimack Pharmaceuticals, Inc.

Last Close

14.73

26/04 20:00

Market Cap

214.05M

Beta: 1.80

Volume Today

55.16K

Avg: 70.31K

PE Ratio

−152.04

PFCF: −135.35

Filings Not Available

Please Sign In To Use The Chat